Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, announced the presentation of preclinical data on the...
GenScript USA Inc., the world's leading life science research tools and services provider, announced the debut of the highest throughput semiconductor chip for DNA...
InxMed Co., Ltd. announced that IN10018, its focal adhesion kinase (FAK) inhibitor, had been granted with Breakthrough Therapy Designation by the China National Medical...
Juniper Biologics, a science-led healthcare company focused on researching, developing and commercializing novel therapies announced that it has gained the licensing rights to develop...
The Oklahoma Proton Center celebrated the graduation of its 4,000th patient. Mr. Eric Green was a 59-year-old prostate cancer patient who chose the Oklahoma...
